Tag Archives: Valeant

Parsley, SAGE, Marathon, and Timing

–with apologies to Simon and Garfunkel, 1966 SIDE A NIR has long been an admirer of how SAGE Therapeutics has been able to leverage predictive power from tiny pilot studies in Severe Status Epilepticus (SRSE) and Post-Partum Depression (PPD)—but today’s … Continue reading

Posted in BioFollies, Biotech | Tagged , , , | 1 Comment

Valeant Needs Autopsy, Not CPR

Neurogram/August 2015: “This brings us to Valeant Pharmaceuticals. We despise Valeant, a company that routinely treats acquired companies like poachers who have machine-gunned an elephant in the veldt, stripping the tusks while leaving the carcass to rot in the tropical … Continue reading

Posted in Big Pharma, BioFollies, Biotech, Muddled Media | Tagged , | 1 Comment

Neurogram+ 10-5-15

Greed Jumps the Shark1 Future pharmarchaeologists may try to unearth and analyze the sequence of events that triggered the eventual imposition of pharma price controls in the United States, for so long the bastion of pharmacoeconomic free enterprise. It is … Continue reading

Posted in Big Pharma, BioFollies, Biotech | Tagged , , | 1 Comment

She Loves Me, She Loves Me Not

NIR has not covered the journey of flibanserin/Addyi , but we have watched with interest, and as the FDA decision loomed, we fielded a couple of calls from print journalists inquiring about our views on this somewhat controversial drug for … Continue reading

Posted in Biotech | Tagged , , , | Leave a comment

Those Who Fail to Learn from Obscenity are Condemned to Repeat It

As May approaches, the ‘Street’ has perked up at the news and rumor, respectively,   of two takeover aspirations: Valeant (with Pershing Square Capital) seeking to buy Allergan for $45.6 billion, Pfizer reportedly considering an offer of $101 billion for Astra … Continue reading

Posted in BioFollies, Biotech | Tagged , | 1 Comment